Syndax Announces Participation at Three Upcoming Investor Conferences

Rhea-AI Summary

Syndax Pharmaceuticals (Nasdaq: SNDX) announced participation in three upcoming virtual investor conferences. The events include the Citi 15th Annual BioPharma Virtual Conference on September 9, 2020, a panel at 11:40 a.m. ET, the Baird 2020 Virtual Global Healthcare Conference on September 10, 2020, with a fireside chat at 4:20 p.m. ET, and the Morgan Stanley 18th Annual Global Virtual Healthcare Conference on September 14, 2020, with a fireside chat at 2:15 p.m. ET. Live webcasts will be available on the company’s website, with a replay following the events.

WALTHAM, Mass., Sept. 2, 2020 /PRNewswire/ -- Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that members of its management team will participate in three upcoming virtual investor conferences. The details for the three conferences are:

• Citi 15th Annual BioPharma Virtual Conference on Wednesday, September 9, 2020. Panel at 11:40 a.m. ET.
• Baird 2020 Virtual Global Healthcare Conference on Thursday, September 10, 2020. Fireside chat at 4:20 p.m. ET.
• Morgan Stanley 18th Annual Global Virtual Healthcare Conference on Monday, September 14, 2020. Fireside chat at 2:15 p.m. ET.

A live webcast of the events can be accessed from the Investor section of the Company's website at www.syndax.com, where a replay of the event will also be available for a limited time.

About Syndax Pharmaceuticals, Inc.

Syndax Pharmaceuticals is a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies. The Company's pipeline includes SNDX-5613, a highly selective inhibitor of the Menin–MLL binding interaction, axatilimab, a monoclonal antibody that blocks the colony stimulating factor 1 (CSF-1) receptor, and entinostat, a class I HDAC inhibitor. For more information, please visit www.syndax.com or follow the Company on Twitter and LinkedIn. .

Syndax Contacts

Investor Contact
Melissa Forst
Argot Partners
melissa@argotpartners.com
Tel 212.600.1902

Media Contact
Ted Held
ted.held@gcihealth.com  
Tel 212.798.9842

SNDX-G

View original content:http://www.prnewswire.com/news-releases/syndax-announces-participation-at-three-upcoming-investor-conferences-301122452.html

SOURCE Syndax Pharmaceuticals, Inc.

FAQ

What are the dates and times for Syndax's investor conferences?

Syndax's investor conferences are: Citi on September 9, 2020, at 11:40 a.m. ET, Baird on September 10, 2020, at 4:20 p.m. ET, and Morgan Stanley on September 14, 2020, at 2:15 p.m. ET.

How can I access the webcasts for Syndax's conferences?

Live webcasts for Syndax's conferences can be accessed on the Investor section of their website and will be available for replay afterward.

What is Syndax Pharmaceuticals known for?

Syndax Pharmaceuticals is a clinical stage biopharmaceutical company developing innovative cancer therapies, including SNDX-5613 and axatilimab.

What is the ticker symbol for Syndax Pharmaceuticals?

The ticker symbol for Syndax Pharmaceuticals is SNDX.

What types of therapies is Syndax developing?

Syndax is developing a pipeline of cancer therapies, including SNDX-5613, axatilimab, and entinostat.